T. Rowe Price Associates’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.31M | Buy |
39,749
+3,723
| +10% | +$158K | ﹤0.01% | 2008 |
|
|
2025
Q4 | $1.67M | Buy |
36,026
+1,061
| +3% | +$44.4K | ﹤0.01% | 1839 |
|
|
2025
Q3 | $1.22M | Sell |
34,965
-1,298
| -4% | -$45.1K | ﹤0.01% | 1967 |
|
|
2025
Q2 | $1.07M | Buy |
36,263
+1,725
| +5% | +$49.2K | ﹤0.01% | 1959 |
|
|
2025
Q1 | $1.03M | Buy |
34,538
+1,400
| +4% | +$42.8K | ﹤0.01% | 1943 |
|
|
2024
Q4 | $950K | Buy |
33,138
+1,977
| +6% | +$65.4K | ﹤0.01% | 1993 |
|
|
2024
Q3 | $1.21M | Buy |
31,161
+300
| +1% | +$10.7K | ﹤0.01% | 1893 |
|
|
2024
Q2 | $994K | Buy |
30,861
+1,579
| +5% | +$54.8K | ﹤0.01% | 1896 |
|
|
2024
Q1 | $1.14M | Buy |
29,282
+535
| +2% | +$18.7K | ﹤0.01% | 1859 |
|
|
2023
Q4 | $885K | Buy |
28,747
+766
| +3% | +$19.2K | ﹤0.01% | 1924 |
|
|
2023
Q3 | $626K | Buy |
27,981
+1,011
| +4% | +$23.1K | ﹤0.01% | 2006 |
|
|
2023
Q2 | $580K | Buy |
26,970
+422
| +2% | +$9.58K | ﹤0.01% | 2053 |
|
|
2023
Q1 | $637K | Sell |
26,548
-1,713
| -6% | -$45.4K | ﹤0.01% | 2005 |
|
|
2022
Q4 | $656K | Buy |
28,261
+669
| +2% | +$13.5K | ﹤0.01% | 2002 |
|
|
2022
Q3 | $443K | Buy |
27,592
+2,012
| +8% | +$35.5K | ﹤0.01% | 2180 |
|
|
2022
Q2 | $453K | Buy |
25,580
+1,425
| +6% | +$24K | ﹤0.01% | 2258 |
|
|
2022
Q1 | $492K | Buy |
24,155
+2,108
| +10% | +$39.8K | ﹤0.01% | 2345 |
|
|
2021
Q4 | $412K | Sell |
22,047
-600
| -3% | -$11.7K | ﹤0.01% | 2480 |
|
|
2021
Q3 | $447K | Sell |
22,647
-100
| -0.4% | -$2.16K | ﹤0.01% | 2430 |
|
|
2021
Q2 | $538K | Sell |
22,747
-3,058
| -12% | -$70.6K | ﹤0.01% | 2361 |
|
|
2021
Q1 | $612K | Buy |
25,805
+4,832
| +23% | +$115K | ﹤0.01% | 2276 |
|
|
2020
Q4 | $420K | Sell |
20,973
-106
| -0.5% | -$2.07K | ﹤0.01% | 2310 |
|
|
2020
Q3 | $439K | Buy |
21,079
+7,300
| +53% | +$132K | ﹤0.01% | 2142 |
|
|
2020
Q2 | $241K | Buy |
13,779
+211
| +2% | +$4.13K | ﹤0.01% | 2316 |
|
|
2020
Q1 | $222K | Sell |
13,568
-82,560
| -86% | -$1.7M | ﹤0.01% | 2284 |
|
|
2019
Q4 | $1.98M | Buy |
96,128
+63,776
| +197% | +$1.06M | ﹤0.01% | 1607 |
|
|
2019
Q3 | $371K | Buy |
32,352
+190
| +0.6% | +$2.17K | ﹤0.01% | 2210 |
|
|
2019
Q2 | $423K | Buy |
32,162
+65
| +0.2% | +$869 | ﹤0.01% | 2175 |
|
|
2019
Q1 | $486K | Buy |
32,097
+100
| +0.3% | +$1.6K | ﹤0.01% | 2121 |
|
|
2018
Q4 | $549K | Sell |
31,997
-10,265
| -24% | -$176K | ﹤0.01% | 2040 |
|
|
2018
Q3 | $623K | Buy |
+42,262
| New | +$749K | ﹤0.01% | 2064 |
|
|
2018
Q2 | – | Sell |
-67,285
| Closed | -$1.72M | – | 2584 |
|
|
2018
Q1 | $1.72M | Buy |
67,285
+3,478
| +5% | +$82.9K | ﹤0.01% | 1618 |
|
|
2017
Q4 | $1.18M | Buy |
+63,807
| New | +$914K | ﹤0.01% | 1739 |
|
Other funds holding COLL
EAM
VCM
